Dan O’Callaghan, Quality Director and Site Head of Quality
Dan O’Callaghan has over 19 years of experience working for Boston Scientific, Clonmel, Ireland. He is the current Quality Director and Site Head of Quality for the site. In his 19 years at Boston Scientific, Dan has held positions of increasing responsibility across Operations, Engineering and Quality. Boston Scientific Clonmel specializes in the manufacture of implantable Pacemakers, Defibrillators, Spinal Cord Stimulators and Deep Brain Stimulators for the worldwide market. Boston Scientific Clonmel, has completed its first MDDAP appraisal in 2018 and is currently preparing for its second appraisal in May of this year.
Conference Track: Improving Capability in the Medical Device Industry
Hear first-hand accounts of adopting CMMI V2.0 from participants of the collaborative FDA pilot program that endeavors to build a culture of quality across the medical device ecosystem. Enrolled device-makers receive a tailored evaluation appraisal to understand their capabilities against industry best practices and identify improvement opportunities. Panelists will speak to individual stories, broader themes, and answer questions.